搜索
ss
Ausun Pharmaceutical

Home  /  About

All categories

Development History

这是描述信息

2010年  奥翔药业成立，厂房开工建设

这是描述信息

2012年  公司第一个车间开始投产

这是描述信息

2014年  与郑州大学签约治疗脑卒中一类新药BZP技术转让

这是描述信息

2016  Passed PMDA audit

这是描述信息

2017  Successfully listed on the Shanghai Stock Exchange

这是描述信息

2020  The company was audited by Russia

 In  2010

  • Founded in April 2010
  • the Company founded the first academician expert workstation in Taizhou City

 In 2012

  • The company's first workshop began production

 In 2014

  • the Company was rated as a High-tech Enterprise
  • Passed US FDA audit.
  • First certification of ISO14001 standard
  • First occupational health and safety standard 18001
  • Contract with Zhengzhou University on technology transfer of BZP, a new drug for the treatment of stroke
  • The company has set up Zhejiang academician expert workstation and high-tech enterprise research and development center
  • The company passed the EU GMP audit and obtained the certificate

In 2015

  • The company applied to go public
  • The company has set up a post-doctoral workstation and a provincial enterprise research institute

 In 2016

  • The company passed PMDA audit

In 2017

  • The company is listed on the Shanghai Stock Exchange

 In 2018

  • The company passed FDA audit again

 In 2019

  • The company passed the Chinese GMP audit

 In 2020

  • The company was audited by Russia

 In 2021

  • First certification of intellectual property management system

 In 2022

  • Recognized as a provincial-level key research institute, national level intellectual property advantage enterprise, and Zhejiang Province intellectual property demonstration enterprise

Copyright © Zhejiang Ausun Pharmaceutical Co., Ltd.  浙ICP备09045528号   Power：300.cn